|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
5/6/24 Omega Therapeutics, Inc. 8-K:2,9 5/6/24 9:291K Donnelley … Solutions/FA
3/28/24 Omega Therapeutics, Inc. 8-K:2,9 3/28/24 9:354K Donnelley … Solutions/FA
11/9/23 Omega Therapeutics, Inc. 8-K:2,9 11/9/23 11:402K Donnelley … Solutions/FA
8/3/23 Omega Therapeutics, Inc. 8-K:1,2,9 8/3/23 13:481K Donnelley … Solutions/FA
5/4/23 Omega Therapeutics, Inc. 8-K:2,9 5/4/23 11:362K Donnelley … Solutions/FA
3/1/23 Omega Therapeutics, Inc. 8-K:2,9 3/1/23 11:431K Donnelley … Solutions/FA
11/8/22 Omega Therapeutics, Inc. 8-K:2 11/8/22 11:453K Donnelley … Solutions/FA
8/4/22 Omega Therapeutics, Inc. 8-K:2,9 8/4/22 11:422K Donnelley … Solutions/FA
5/4/22 Omega Therapeutics, Inc. 8-K:2,9 5/4/22 11:346K Donnelley … Solutions/FA
3/10/22 Omega Therapeutics, Inc. 8-K:2,9 3/10/22 11:427K Donnelley … Solutions/FA
11/10/21 Omega Therapeutics, Inc. 8-K:2,9 11/10/21 11:376K Donnelley … Solutions/FA
9/10/21 Omega Therapeutics, Inc. 8-K:2,9 9/10/21 11:438K ActiveDisclosure/FA
____________ | ¹ | Filing/Form Type: | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. |
|